h.fonseca
TL2 Moderator · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 18 March 2025 · last posted 3d
78 posts, newest first. Showing up to 150.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #47 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #22 · Evidence › Study critique · 18 Jul 2026 · 23 likes Coming back to post #20, because the follow-up matters more than the original answer. Defending a paper against criticism: if the authors respond, they might clarify…
-
Does a peptide degrade silently, with no visual change? Replied, post #73 · Practice › Storage & stability · 18 Jul 2026 · 30 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Follow-up: Sleep quality changes during weight loss Replied, post #71 · Wellbeing › Sleep · 16 Jul 2026 · 25 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 3 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #108 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 3 likes post #107 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #69 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 13 likes post #68 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Aggregate verification data across the directory, with caveats Replied, post #29 · Sourcing › Independent verification · 5 Jul 2026 · 14 likes post #28 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Coming back to: Telehealth prescribing models in the US Replied, post #3 · Regional › North America · 2 Jul 2026 · 0 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #33 · Documentation › Doc review · 30 Jun 2026 · 25 likes Coming back to post #31, because the follow-up matters more than the original answer. Evidence synthesis requests: if you think a page should summarise the state of…
-
What to include when your question involves a chromatogram — one year on Replied, post #51 · Start Here › How to Ask · 25 Jun 2026 · 30 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #55 · Outcomes › Progress reports · 5 Jun 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Alcohol: what is documented and what is folklore Replied, post #26 · Practice › Interactions · 25 May 2026 · 16 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Official shortage notices and what they authorise Replied, post #45 · Access › Shortages · 12 May 2026 · 12 likes post #44 is right about the mechanism and I think understates the practical bit. International supply chains: a shortage in one country does not mean shortage in…
-
Why fasting instructions for oral semaglutide are not optional advice Started this topic · Compounds › Oral incretins · 11 May 2026 · 2 likes Why fasting instructions for oral semaglutide are not optional advice I have a specific reason for asking rather than idle curiosity, and the context is below. I have…
-
How much fluid is actually needed, and how you would know Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 7 May 2026 · 22 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Search filters: what is missing Replied, post #51 · Meta › Site feedback · 27 Apr 2026 · 0 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #51 · Practice › Administration · 22 Apr 2026 · 0 likes Picking up post #48: that is the part I would want checked first. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether…
-
Preservatives: function, testing, and limits — one year on Replied, post #10 · Pharmacology › Formulation chemistry · 14 Apr 2026 · 10 likes Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
-
Revisiting: Absolute versus relative contraindications Replied, post #55 · Safety › Contraindications · 30 Mar 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #5 · Compounds › Repair & healing peptides · 28 Mar 2026 · 14 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #30 · Clinical › Comorbidities · 26 Mar 2026 · 3 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #26 · Sourcing › Logistics · 26 Mar 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #21 · Compounds › Repair & healing peptides · 13 Mar 2026 · 7 likes post #20 is right about the mechanism and I think understates the practical bit. The absence of adequately powered published randomised human trials is the central fact…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #30 · Practice › Administration · 12 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #56 · Analytics › Impurities & related substances · 17 Feb 2026 · 6 likes Coming back to post #54, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #66 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #45 · Clinical › Bloodwork · 3 Feb 2026 · 17 likes Worth separating two things that post #41 runs together. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment.…
-
Tag proliferation and whether we should prune — what changed since Replied, post #5 · Meta › Site feedback · 25 Jan 2026 · 0 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #39 · Research Methods › N-of-1 designs · 24 Jan 2026 · 3 likes post #38 is right about the mechanism and I think understates the practical bit. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings,…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #48 · Documentation › Doc review · 10 Jan 2026 · 14 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Pen dose counters: what a click does and does not guarantee Replied, post #86 · Devices › Pens & autoinjectors · 18 Nov 2025 · 12 likes Coming back to post #84, because the follow-up matters more than the original answer. Injection duration: most pens deliver the dose over several seconds. Holding the…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #50 · Compounds › Tirzepatide · 12 Nov 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Insurance and replacement policies, compared — the long version Replied, post #31 · Sourcing › Logistics · 25 Oct 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #27 · Compounds › Semaglutide · 23 Oct 2025 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #22 · Analytics › Home & field testing · 2 Oct 2025 · 1 like On post #18 — agreed on the reasoning, with one qualification. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #18 · Compounds › Semaglutide · 30 Sep 2025 · 15 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Follow-up: Why appetite effects are mostly central Replied, post #47 · Pharmacology › Receptor biology · 22 Sep 2025 · 0 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #122 · Data & Tools › Calculators · 19 Sep 2025 · 0 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #110 · Compounds › Retatrutide · 12 Sep 2025 · 0 likes post #109 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #44 · Practice › Side effects · 7 Sep 2025 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #12 · Practice › Interactions · 4 Sep 2025 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Insomnia at a dose step: reported experiences Replied, post #7 · Wellbeing › Sleep · 27 Aug 2025 · 27 likes post #6 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #99 · Clinical › Comorbidities · 23 Aug 2025 · 0 likes Coming back to post #97, because the follow-up matters more than the original answer. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #66 · Evidence › Journal club · 19 Aug 2025 · 10 likes I read post #64 twice before replying, because I had assumed the opposite. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #15 · Evidence › Journal club · 12 Aug 2025 · 3 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #88 · Compounds › Repair & healing peptides · 1 Aug 2025 · 10 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #22 · Devices › Pens & autoinjectors · 2 Jul 2025 · 2 likes Worth separating two things that post #18 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #68 · Devices › Pens & autoinjectors · 16 Jun 2025 · 19 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Reading an MS report that only gives you a single number Replied, post #104 · Analytics › Mass spectrometry · 10 Jun 2025 · 2 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #18 · Access › Insurance & coverage · 7 Jun 2025 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #50 · Clinical › Comorbidities · 27 May 2025 · 17 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #34 · Evidence › Trials · 20 May 2025 · 10 likes Coming back to post #32, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #117 · Compounds › Cagrilintide & amylin analogues · 17 May 2025 · 0 likes Coming back to post #115, because the follow-up matters more than the original answer. What is genuinely unknown about long-term amylin agonism: real-world response…
-
Pregnancy as an absolute contraindication Replied, post #13 · Safety › Contraindications · 17 May 2025 · 1 like post #12 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Documentation that appears only after payment Replied, post #42 · Sourcing › Red flags · 3 May 2025 · 6 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #96 · Compounds › Semaglutide · 29 Apr 2025 · 5 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #59 · Compounds › Secretagogues & GH axis · 15 Apr 2025 · 8 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #127 · Sourcing › Regulatory · 12 Apr 2025 · 6 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
A well-designed study with a badly written abstract Replied, post #17 · Evidence › Study critique · 10 Apr 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 24 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #103 · Sourcing › Vendor reports · 18 Mar 2025 · 25 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #26 · Sourcing › Independent verification · 7 Mar 2025 · 29 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #24 · Sourcing › Regulatory · 28 Feb 2025 · 1 like post #23 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #67 · Analytics › Mass spectrometry · 23 Feb 2025 · 6 likes Resolution: "high resolution" commonly means
-
Protein density versus volume when you cannot eat much Replied, post #96 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 23 likes post #95 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Regression to the mean in progress reports Replied, post #49 · Research Methods › Statistics · 8 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #25 · Evidence › Meta-analyses · 28 Jan 2025 · 22 likes Worth separating two things that post #21 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #66 · Data & Tools › Calculators · 26 Jan 2025 · 32 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
Recovery when intake is low: what to cut first Replied, post #78 · Nutrition & Training › Resistance training · 14 Jan 2025 · 0 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #147 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes post #146 is right about the mechanism and I think understates the practical bit. Why administration conditions matter for oral semaglutide and not for injectables: the…
-
What a simple presence test is genuinely useful for — does this still hold? Started this topic · Analytics › Home & field testing · 12 Nov 2024 · 52 likes What a simple presence test is genuinely useful for — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I…
-
Transporting a vial for a weekend away Replied, post #19 · Practice › Storage & stability · 30 Oct 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #29 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #14 · Clinical › Comorbidities · 2 Oct 2024 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in…
-
About the Protein & intake category Replied, post #5 · Nutrition & Training › Protein & intake · 10 Sep 2024 · 1 like Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #41 · Practice › Dosing & titration · 7 Jul 2024 · 22 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…